Susan Chor is an Equity Research associate on the US Biopharmaceuticals team, covering Large & SMid Cap Biotech and Major Pharma. Prior to joining BofA she was an Equity Research associate at Oppeneimer & Co. covering SMid Cap Biotech and Diagnostics. She has a BA in Biology and East Asian Languages and Civilizations from the University of Pennsylvania. Chor is based in New York.